Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06571305 · ClinicalTrials.gov registry record · NA

FAMILY Sleep Program

A NA study of Cancer, sponsored by University of Miami.

Recruiting
Registry status
NA
Development phase
12
Enrollment target
1
Study location

NCT06571305: Recruiting NA study of Cancer, sponsored by University of Miami.

NCT06571305 is a NA study of Cancer that is actively recruiting participants, run by University of Miami. The registered enrollment target is 12 participants, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (100% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06571305, a NA study of Cancer, is actively recruiting participants, sponsored by University of Miami.

RECRUITING
Registry status
NA
Development phase
12 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn about sleep behaviors and test different ways to help patients with cancer and partners. Participants (patient-sleep-partner caregivers dyads as a unit) participate in the study together.

Primary Outcome

The proportion of participants (patient--sleep-partner caregiver dyads) who adapt to Brief Behavioral Treatment for Insomnia (BBTI).

Conditions Studied

Interventions

  • BEHAVIORAL Brief Behavioral Treatment for Insomnia (BBTI)
  • BEHAVIORAL My Sleep Our Sleep (MSOS)

Study Locations (1)

Florida

  • University of Miami - Coral Gables

Trial Details

FieldValue
Enrollment Target 12 participants
Start Date 2024-08-01
Est. Completion 2026-10-01
Phase NA
University of Miami

721 total trials

What NCT06571305 shows while recruiting

NCT06571305 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 12 participants, a relatively small participant target, below the 3,491-participant average among 615 other Cancer trials with a reported enrollment target (100% lower).

The record links to 1 condition, with Cancer appearing as the primary indexed condition, and to 2 interventions - of which Brief Behavioral Treatment for Insomnia (BBTI) is the first listed.

NCT06571305 reports a single indexed study location in Florida.

Frequently Asked Questions

What is clinical trial NCT06571305 about?

NCT06571305 is a clinical study titled "FAMILY Sleep Program". The purpose of this study is to learn about sleep behaviors and test different ways to help patients with cancer and partners. Participants (patient-sleep-partner caregivers dyads as a unit) participate in the study together.

What is the current status of trial NCT06571305?

This trial is currently recruiting. It is a NA study. The enrollment target is 12 participants. The study started on 2024-08-01. Estimated completion is 2026-10-01.

What conditions does trial NCT06571305 study?

This clinical trial studies the following conditions: Cancer.

What interventions are being tested in trial NCT06571305?

The interventions under investigation include: Brief Behavioral Treatment for Insomnia (BBTI) (BEHAVIORAL), My Sleep Our Sleep (MSOS) (BEHAVIORAL).

Who is sponsoring clinical trial NCT06571305?

This trial is sponsored by University of Miami, which has 721 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06571305 being conducted?

This trial has 1 study location across Florida. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cancer

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06571305's enrollment target sits among peer trials

12 594th of 615 higher than 18 of 615 other Cancer trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cancer trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT02602769 · 12 participants

    Whole Transcriptome Profiling and Metabolic Phenotyping in Children With ROHHAD Syndrome

  • NCT02605421 · 12 participants · Phase 2

    Myeloablative Consolidation Therapy and Tandem Autologous Stem Cell Rescue in Patients With High-Risk Neuroblastoma

  • NCT02619448 · 12 participants · Early Phase 1

    Concurrent Chemotherapy Plus HFR Radiation Therapy in Inoperable NSCLC

  • NCT03311503 · 12 participants · Phase 1

    Phase I/II Trial of Lentiviral Gene Transfer for SCID-X1 With Low Dose Targeted Busulfan Conditioning

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06571305, the US trial registry maintained by the National Library of Medicine. NCT06571305 (small enrollment · single site footprint · recruiting) retrieved and formatted by PlainTrial, see methodology.